DK509088A - 17-spiro-steroider, deres fremstilling samt laegemidler med indhold deraf - Google Patents

17-spiro-steroider, deres fremstilling samt laegemidler med indhold deraf

Info

Publication number
DK509088A
DK509088A DK509088A DK509088A DK509088A DK 509088 A DK509088 A DK 509088A DK 509088 A DK509088 A DK 509088A DK 509088 A DK509088 A DK 509088A DK 509088 A DK509088 A DK 509088A
Authority
DK
Denmark
Prior art keywords
preparation
steroids
spiro
medicinal products
image
Prior art date
Application number
DK509088A
Other languages
English (en)
Other versions
DK509088D0 (da
DK174268B1 (da
Inventor
Andre Claussner
Martine Moguilewsky
Lucien Nedelec
Daniel Philibert
Original Assignee
Roussel Uclaf
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Roussel Uclaf filed Critical Roussel Uclaf
Publication of DK509088D0 publication Critical patent/DK509088D0/da
Publication of DK509088A publication Critical patent/DK509088A/da
Application granted granted Critical
Publication of DK174268B1 publication Critical patent/DK174268B1/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0033—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
    • C07J41/0077—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 substituted in position 11-beta by a carbon atom, further substituted by a group comprising at least one further carbon atom
    • C07J41/0083—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 substituted in position 11-beta by a carbon atom, further substituted by a group comprising at least one further carbon atom substituted in position 11-beta by an optionally substituted phenyl group not further condensed with other rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J21/00—Normal steroids containing carbon, hydrogen, halogen or oxygen having an oxygen-containing hetero ring spiro-condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J21/00—Normal steroids containing carbon, hydrogen, halogen or oxygen having an oxygen-containing hetero ring spiro-condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C07J21/005—Ketals
    • C07J21/006—Ketals at position 3
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J31/00—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring
    • C07J31/006—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring not covered by C07J31/003
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
    • C07J71/0005—Oxygen-containing hetero ring
    • C07J71/001—Oxiranes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Glass Compositions (AREA)
  • Physical Or Chemical Processes And Apparatus (AREA)
DK198805090A 1987-09-18 1988-09-13 17-spiro-steroider, deres fremstilling samt lægemidler med indhold deraf DK174268B1 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR8712937A FR2620707B1 (fr) 1987-09-18 1987-09-18 Nouveaux steroides comportant un cycle spirannique a 3, 4 ou 6 chainons en position 17, leur procede et des intermediaires de preparation, leur application comme medicaments et les compositions pharmaceutiques les renfermant
FR8712937 1987-09-18

Publications (3)

Publication Number Publication Date
DK509088D0 DK509088D0 (da) 1988-09-13
DK509088A true DK509088A (da) 1989-05-23
DK174268B1 DK174268B1 (da) 2002-10-28

Family

ID=9355024

Family Applications (1)

Application Number Title Priority Date Filing Date
DK198805090A DK174268B1 (da) 1987-09-18 1988-09-13 17-spiro-steroider, deres fremstilling samt lægemidler med indhold deraf

Country Status (18)

Country Link
US (1) US4921846A (da)
EP (1) EP0308345B1 (da)
JP (1) JP2794297B2 (da)
KR (1) KR960013446B1 (da)
CN (1) CN1031942C (da)
AT (1) ATE88716T1 (da)
CA (1) CA1340344C (da)
DE (1) DE3880601T2 (da)
DK (1) DK174268B1 (da)
ES (1) ES2054844T3 (da)
FR (1) FR2620707B1 (da)
GR (1) GR3008221T3 (da)
HU (1) HU199505B (da)
IE (1) IE61751B1 (da)
MX (1) MX174142B (da)
PT (1) PT88536B (da)
SU (1) SU1665877A3 (da)
ZA (1) ZA886820B (da)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2665901B2 (fr) * 1989-02-24 1994-07-29 Roussel Uclaf Nouveaux 19-nor sterouides ayant en position 11beta une chaine carbonee comportant une fonction amide, leur preparation, leur application comme medicaments.
DE3921059A1 (de) * 1989-06-23 1991-01-10 Schering Ag 11(beta)-aryl-4-estrene, verfahren zu ihrer herstellung sowie deren verwendung als arzneimittel
WO1991001958A2 (de) * 1989-08-04 1991-02-21 Schering Aktiengesellschaft Berlin Und Bergkamen 11β-ARYL-GONA-4,9-DIEN-3-ONE
FR2651233B1 (fr) * 1989-08-23 1991-12-13 Roussel Uclaf Nouveaux acides omega-phenylamino alcanouiques substitues sur le noyau aromatique par un radical derive de 19-norsterouides, leur procede de preparation, leur application a titre de medicaments et les compositions les renfermant.
DE4008584A1 (de) * 1990-03-15 1991-09-26 Schering Ag Verfahren zur herstellung von zwischenprodukten fuer die antigestagensynthese (onapristonsynthese)
ES2112268T3 (es) * 1990-08-14 1998-04-01 Hoechst Marion Roussel Inc Nuevos 19-nor-esteroides que tienen en posicion 11beta una cadena carbonada que comprende una funcion amida, su preparacion, su aplicacion como medicamentos y composiciones farmaceuticas que los contienen.
US5407928A (en) * 1990-08-15 1995-04-18 Schering Aktiengesellschaft 11β-aryl-gona-4,9-dien-3-ones
CA2100514C (en) * 1992-07-29 2005-03-29 Johannes A. M. Hamersma 17-spiromethylene steroids
FR2757399B1 (fr) * 1996-12-23 1999-12-17 Hoechst Marion Roussel Inc Application de composes steroides substitues en 11 pour la fabrication de medicaments ayant une activite estrogene dissociee
US6020328A (en) * 1998-03-06 2000-02-01 Research Triangle Institute 20-keto-11β-arylsteroids and their derivatives having agonist or antagonist hormonal properties
ES2347027T3 (es) 1998-05-22 2010-10-22 The Board Of Trustees Of The Leland Stanford Junior University Moleculas bifuncionales y terapias basadas en las mismas.
EP3827747A1 (en) 2005-04-28 2021-06-02 Otsuka Pharmaceutical Co., Ltd. Pharma-informatics system
EP1945240B1 (en) 2005-09-16 2016-12-28 Raptor Pharmaceutical Inc Compositions comprising receptor-associated protein (rap) variants specific for cr-containing proteins and uses thereof
EP1862468A1 (de) * 2006-06-02 2007-12-05 Bayer Schering Pharma Aktiengesellschaft Kristallines 11beta-(4-Acetylphenyl)-20,20,21,21,21-pentafluor-17-hydroxy-19-nor-17alpha-pregna-4,9-dien-3-on
HUE059078T2 (hu) 2009-02-20 2022-10-28 Enhanx Biopharm Inc Glutation-alapú hatóanyagszállító rendszer
IL295075A (en) 2009-05-06 2022-09-01 Laboratory Skin Care Inc Preparations for administration through the skin that include complexes of an active substance with calcium phosphate and methods of using them
DE102009034368A1 (de) 2009-07-20 2011-01-27 Bayer Schering Pharma Aktiengesellschaft 17-Hydroxy-17-pentafluorethyl-estra-4,9(10)-dien-11-acyloxyalkylenphenyl-Derivate, Verfahren zu ihrer Herstellung und ihre Verwendung zur Behandlung von Krankheiten
DE102009034362A1 (de) 2009-07-20 2011-01-27 Bayer Schering Pharma Aktiengesellschaft 17-Hydroxy-17-pentafluorethyl-estra-4,9(10)-dien-11-aryl-Derivate, Verfahren zu ihrer Herstellung und ihre Verwendung zur Behandlung von Krankheiten
DE102009034366A1 (de) 2009-07-20 2011-01-27 Bayer Schering Pharma Aktiengesellschaft 17-Hydroxy-17-pentafluorethyl-estra-4,9(10)-dien-11-methylenoxyalkylenaryl-Derivate, Verfahren zu ihrer Herstellung und ihre Verwendung zur Behandlung von Krankheiten
DE102009034367A1 (de) 2009-07-20 2011-01-27 Bayer Schering Pharma Aktiengesellschaft 17-Hydroxy-17-pentafluorethyl-estra-4,9(10)-dien-11-benzyliden-Derivate, Verfahren zu deren Herstellung und deren Verwendung zur Behandlung von Krankheiten
DE102009034525A1 (de) 2009-07-21 2011-01-27 Bayer Schering Pharma Aktiengesellschaft 17-Hydroxy-17-pentafluorethyl-estra-4,9(10)-dien-11-aryl-Derivate, Verfahren zu ihrer Herstellung und ihre Verwendung zur Behandlung von Krankheiten
DE102009034526A1 (de) 2009-07-21 2011-02-10 Bayer Schering Pharma Aktiengesellschaft 17-Hydroxy-17-pentafluorethyl-estra-4,9(10)-dien-11-ethinylphenyl-Derivate, Verfahren zu deren Herstellung und deren Verwendung zur Behandlung von Krankheiten
DE102010007719A1 (de) 2010-02-10 2011-08-11 Bayer Schering Pharma Aktiengesellschaft, 13353 Progesteronrezeptorantagonisten
DE102010007722A1 (de) 2010-02-10 2011-08-11 Bayer Schering Pharma Aktiengesellschaft, 13353 Progesteronrezeptorantagonisten

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3364207A (en) * 1962-08-13 1968-01-16 Searle & Co Polyhydrospiro[estr/androst-4-ene-17, 2'-furan/pyran]-3-one and intermediates
US3422096A (en) * 1967-08-08 1969-01-14 Searle & Co Spiro(estrene/androstene-17,2'-oxetane)-3-one and intermediates
FR2377418A1 (fr) * 1977-01-13 1978-08-11 Roussel Uclaf Nouveaux derives steroides 4,9-dieniques 11b-substitues, leur procede de preparation et leur application comme medicaments
DE3026783C2 (de) * 1980-07-11 1982-07-29 Schering Ag, 1000 Berlin Und 4619 Bergkamen Verfahren zur Herstellung von 5β-Hydroxy-δ↑6↑-steroiden
FR2528434B1 (fr) * 1982-06-11 1985-07-19 Roussel Uclaf Nouveaux 19-nor steroides substitues en 11b et eventuellement en 2, leur procede de preparation et leur application comme medicament
FR2522328B1 (fr) * 1982-03-01 1986-02-14 Roussel Uclaf Nouveaux produits derives de la structure 3-ceto 4,9 19-nor steroides, leur procede de preparation et leur application comme medicaments
DE3461090D1 (en) * 1983-02-18 1986-12-04 Schering Ag 11-beta-aryl-estradienes, process for their preparation and pharmaceutical compositions containing them
DE3347126A1 (de) * 1983-12-22 1985-07-11 Schering AG, 1000 Berlin und 4709 Bergkamen 11ss-aryl-estradiene, deren herstellung und diese enthaltende pharmazeutische praeparate
DE3410880A1 (de) * 1984-03-21 1985-10-03 Schering AG, Berlin und Bergkamen, 1000 Berlin 17-substituierte estradiene und estratriene
FR2596395B1 (fr) * 1986-03-26 1989-05-26 Roussel Uclaf Nouveaux steroides comportant un cycle spirannique en position 17, leur procede de preparation, leur application comme medicaments et les compositions les renfermant

Also Published As

Publication number Publication date
KR960013446B1 (ko) 1996-10-05
US4921846A (en) 1990-05-01
EP0308345A1 (fr) 1989-03-22
FR2620707B1 (fr) 1989-12-08
KR890005143A (ko) 1989-05-13
HUT48275A (en) 1989-05-29
ZA886820B (en) 1989-11-29
IE882813L (en) 1989-03-18
ES2054844T3 (es) 1994-08-16
SU1665877A3 (ru) 1991-07-23
CN1031942C (zh) 1996-06-05
EP0308345B1 (fr) 1993-04-28
HU199505B (en) 1990-02-28
JPH01106899A (ja) 1989-04-24
ATE88716T1 (de) 1993-05-15
IE61751B1 (en) 1994-11-30
DE3880601T2 (de) 1993-10-07
PT88536A (pt) 1988-10-01
JP2794297B2 (ja) 1998-09-03
MX174142B (es) 1994-04-25
PT88536B (pt) 1992-11-30
DK509088D0 (da) 1988-09-13
CA1340344C (fr) 1999-01-26
DE3880601D1 (de) 1993-06-03
DK174268B1 (da) 2002-10-28
MX13052A (es) 1993-09-01
CN1034207A (zh) 1989-07-26
GR3008221T3 (da) 1993-09-30
FR2620707A1 (fr) 1989-03-24

Similar Documents

Publication Publication Date Title
DK509088A (da) 17-spiro-steroider, deres fremstilling samt laegemidler med indhold deraf
FR2680512B1 (fr) Nouveaux derives de 2,4-thiazolidinedione, leur procede de preparation et les compositions pharmaceutiques qui les contiennent.
FR2679906B1 (fr) Nouvelles (isoquinolein-5 yl) sulfonamides, leur procede de preparation et les compositions pharmaceutiques qui les contiennent.
IL76457A (en) Tetralin derivatives,their preparation and pharmaceutical compositions containing them
NZ236589A (en) A-nor-steroid-3-carboxylic acid derivatives and pharmaceutical compositions
DE68914488T2 (de) 2-(2-Hydroxy-3-phenoxypropylamino)ethylphenoxyacetamide, Verfahren und Zwischenprodukte zu deren Herstellung.
FI875202A (fi) Steroider med en spiranring i 17-staellning, foerfarande foer framstaellning av dessa och anvaendning av dessa.
IT1194748B (it) Composizioni farmaceutiche per il trattamento di osteopatie
ZA806399B (en) New 2-hydroxyalkyl-3,4,5-trihydroxypiperidine compounds, their production and their medicinal use
DK0558416T3 (da) 17-methylenlactonsteroider, deres fremstilling, mellemprodukter dertil, deres anvendelse som lægemidler samt farmaceutiske præparater med indhold deraf
JPS6438086A (en) Mevalonic acid derivative and manufacture
PT87024A (pt) Process for the preparation of propiolophenone derivatives and of pharmaceutical compositions containing the same
PT87535A (pt) Process for the preparation of novel anf peptide derivatives and of pharmaceutical compositions containing the same
PT87550A (pt) Process for the preparation of pyrimidine derivatives and of pharmaceutical compositions containing the same
PH20421A (en) Derivatives of piperidinedione for protecting the myocardium presenting an anti-arrythmic activity and pharmaceutical compositions containing them
PT87202A (pt) Process for the preparation of novel acyl derivatives and of pharmaceutical compositions containing the same
PT82364B (fr) Procede de preparation de derives du nitrofuranne et de compositions pharmaceutiques les contenant
GR3020508T3 (en) Derivatives of 20,21-dinoreburnamenine, process for their preparation and intermediates, their use as medicines and compositions containing them
ZA855156B (en) Novel ether-oxides derived from cyclopropylphenols
PT87301A (pt) Process for the preparation of 1,3-dioxanes by products and of pharmaceutical compounds containing them
DK0443957T3 (da) Hidtil ukendte steroid-forbindelser med en spirogruppe i position 17, en fremgangsmåde og mellemprodukter til fremstilling deraf, deres anvendelse som lægemiddel og farmaceutiske præparater med indhold deraf
EP0395528A3 (fr) Dérivés du 4-phénylméthyl 1H-indole, procédé et intermédiaires de préparation, application à titre de médicaments et compositions les renfermant.
PT87031A (pt) Process for the preparation of 4-phenylpiperidine compounds an d of pharmaceutical compositions therewith
DK0457215T3 (da) 3-deamino-4-desoxy-4-amino-8-fluoranthracycliner samt fremgangsmåder til fremstilling deraf
DK0418990T3 (da) 13-brom- og 13,14-dibrom-ergoliner, deres fremstilling og anvendelse i lægemidler

Legal Events

Date Code Title Description
B1 Patent granted (law 1993)
PBP Patent lapsed

Country of ref document: DK